Phase II study of crizotinib in patients with MET amplification and MET exon 14 deletion: Results from NCI-MATCH ECOG-ACRIN trial (EAY131) subprotocols C1 and C2.Niamh Coleman,Zihan Wei,David S. Hong,Edith P. Mitchell,James A. Zwiebel,Elad Sharon,Robert James Gray,Victoria Wang,Lisa McShane,Larry V. Rubinstein,David R. Patton,P. Mickey Williams,James V. Tricoli,Barbara A. Conley,Carlos L. Arteaga,Lyndsay Harris,Peter J. O'Dwyer,Alice P. Chen,Keith Flaherty,Stanley R. HamiltonJOURNAL OF CLINICAL ONCOLOGY（2023）引用 0|浏览23暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
